The Long Noncoding RNA LINC02820 Promotes Tumor Growth and Metastasis Through Regulating MYH9 Expression in Esophageal Squamous Cell Carcinoma

Abstract

Long noncoding RNAs (lncRNAs) play important roles in tumorigenesis, but their biological functions and mechanisms in esophageal squamous cell carcinoma (ESCC) remain poorly understood. In this study, we employed high-throughput sequencing and bioinformatics analyses to identify the differentially expressed lncRNAs between ESCC tumors and adjacent normal tissues, among which LINC02820 is significantly upregulated in ESCC. Rapid amplification of cDNA ends assays determined the transcription initiation and termination sites of LINC02820, confirming it as a novel transcript variant localized in both the nucleus and cytoplasm of ESCC cells. Functional studies demonstrated that LINC02820 promotes cell proliferation and migration in vitro and enhances tumor growth and metastasis in vivo. Mechanistically, LINC02820 interacts with Myosin-9 protein and prevent it from ubiquitination-mediated proteasomal degradation. Additionally, the RNA-binding protein insulin-like growth factor 2 mRNA-binding protein 2 binds to LINC02820 and increase its RNA stability in ESCC cells, thus upregulating LINC02820 expression. Therefore, these findings indicate LINC02820 as an oncogenic lncRNA in ESCC progression and suggest its potential as a therapeutic target.

Keywords

esophageal squamous cell carcinoma / LINC02820 / MYH9 / IGF2BP2

References

[1] M. di Pietro, M. I. Canto, and F. RC, “Endoscopic Management of Early Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Screening, Diagnosis, and Therapy,” Gastroenterology 154, no. 2 (2018): 421-436.

[2] E. C. Smyth, J. Lagergren, R. C. Fitzgerald, et al., “Oesophageal Cancer,” Nature reviews Disease Primers 3 (2017): 17048.

[3] K. D. Miller, L. Nogueira, A. B. Mariotto, et al., “Cancer Treatment and Survivorship Statistics, 2019,” CA: A Cancer Journal for Clinicians 69, no. 5 (2019): 363-385.

[4] A. M. Schmitt and H. Y. Chang, “Long Noncoding RNAs in Cancer Pathways,” Cancer Cell 29, no. 4 (2016): 452-463.

[5] S. Adnane, A. Marino, and E. Leucci, “LncRNAs in human Cancers: Signal From Noise,” Trends in Cell Biology 32, no. 7 (2022): 565-573.

[6] F. Kopp and J. T. Mendell, “Functional Classification and Experimental Dissection of Long Noncoding RNAs,” Cell 172, no. 3 (2018): 393-407.

[7] H. Lee, Z. Zhang, and H. M. Krause, “Long Noncoding RNAs and Repetitive Elements: Junk or Intimate Evolutionary Partners?,” Trends in Genetics 35, no. 12 (2019): 892-902.

[8] Q. Feng, H. Zhang, D. Yao, et al., “Emerging Role of Non-coding RNAs in Esophageal Squamous Cell Carcinoma,” International Journal of Molecular Sciences 21, no. 1 (2019).

[9] Y. Hosono, Y. S. Niknafs, J. R. Prensner, et al., “Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA,” Cell 171, no. 7 (2017): 1559-1572. e1520.

[10] M. Luo, Z. Li, W. Wang, et al., “Long Non-coding RNA H19 Increases Bladder Cancer Metastasis by Associating With EZH2 and Inhibiting E-cadherin Expression,” Cancer Letters 333, no. 2 (2013): 213-221.

[11] M. Zhou, S. Bao, T. Gong, et al., “The Transcriptional Landscape and Diagnostic Potential of Long Non-coding RNAs in Esophageal Squamous Cell Carcinoma,” Nature Communications 14, no. 1 (2023): 3799.

[12] J. J. Xie, Y. Y. Jiang, Y. Jiang, et al., “Super-enhancer-driven Long Non-coding RNA LINC01503, Regulated by TP63, Is Over-expressed and Oncogenic in Squamous Cell Carcinoma,” Gastroenterology 154, no. 8 (2018): 2137-2151. e2131.

[13] S. T. Xue, B. Zheng, S. Q. Cao, et al., “Long Non-coding RNA LINC00680 Functions as a ceRNA to Promote Esophageal Squamous Cell Carcinoma Progression Through the miR-423-5p/PAK6 Axis,” Molecular Cancer 21, no. 1 (2022): 69.

[14] Y. Cui, C. Zhang, S. Ma, et al., “RNA m6A Demethylase FTO-mediated Epigenetic Up-regulation of LINC00022 Promotes Tumorigenesis in Esophageal Squamous Cell Carcinoma,” Journal of Experimental & Clinical Cancer Research 40, no. 1 (2021): 294.

[15] Y. Liu, C. Li, L. Fang, et al., “Lipid Metabolism-related lncRNA SLC25A21-AS1 Promotes the Progression of Oesophageal Squamous Cell Carcinoma by Regulating the NPM1/c-Myc Axis and SLC25A21 Expression,” Clinical and Translational Medicine 12, no. 6 (2022): e944.

[16] Y. Jia, C. Tian, H. Wang, et al., “Long Non-coding RNA NORAD/miR-224-3p/MTDH Axis Contributes to CDDP Resistance of Esophageal Squamous Cell Carcinoma by Promoting Nuclear Accumulation of β-catenin,” Molecular Cancer 20, no. 1 (2021): 162.

[17] J. Liu, Z. X. Liu, Q. N. Wu, et al., “Long Noncoding RNA AGPG Regulates PFKFB3-mediated Tumor Glycolytic Reprogramming,” Nature Communications 11, no. 1 (2020): 1507.

[18] K. Nemeth, R. Bayraktar, M. Ferracin, et al., “Non-coding RNAs in Disease: From Mechanisms to Therapeutics,” Nature Reviews Genetics 25, no. 3 (2024): 211-232.

[19] T. Mondal, S. Subhash, R. Vaid, et al., “MEG3 long Noncoding RNA Regulates the TGF-β Pathway Genes Through Formation of RNA-DNA Triplex Structures,” Nature Communications 6 (2015): 7743.

[20] A. Keniry, D. Oxley, P. Monnier, et al., “The H19 lincRNA Is a Developmental Reservoir of miR-675 That Suppresses Growth and Igf1r,” Nature Cell Biology 14, no. 7 (2012): 659-665.

[21] M. Huarte, M. Guttman, D. Feldser, et al., “A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response,” Cell 142, no. 3 (2010): 409-419.

[22] Z. Zhang, Y. X. Lu, F. Liu, et al., “lncRNA BREA2 Promotes Metastasis by Disrupting the WWP2-mediated Ubiquitination of Notch1,” PNAS 120, no. 8 (2023): e2206694120.

[23] Y. P. Hu, Y. P. Jin, X. S. Wu, et al., “LncRNA-HGBC Stabilized by HuR Promotes Gallbladder Cancer Progression by Regulating miR-502-3p/SET/AKT Axis,” Molecular cancer 18, no. 1 (2019): 167.

[24] J. Wang, L. Chen, and P. Qiang, “The Role of IGF2BP2, an m6A Reader Gene, in human Metabolic Diseases and Cancers,” Cancer cell international 21, no. 1 (2021): 99.

[25] Y. Zheng, X. Li, S. Deng, et al., “CSTF2 mediated mRNA N(6)-methyladenosine Modification Drives Pancreatic Ductal Adenocarcinoma M(6)A Subtypes,” Nature Communications 14, no. 1 (2023): 6334.

[26] X. Hu, W. X. Peng, H. Zhou, et al., “IGF2BP2 regulates DANCR by Serving as an N6-methyladenosine Reader,” Cell Death and Differentiation 27, no. 6 (2020): 1782-1794.

[27] T. Zhang, X. Tang, Y. Zhu, et al., “IGF2BP2 enhances LincRNA01116 Stability via M(6) A: A Potential Biomarker and Therapeutic Target for Patients With Pre-eclampsia,” Journal of Cellular Biochemistry 124, no. 2 (2023): 239-253.

[28] Q. Liu, C. Cheng, J. Huang, et al., “MYH9: A Key Protein Involved in Tumor Progression and Virus-related Diseases,” Biomedicine & Pharmacotherapy 171 (2024): 116118.

[29] Q. Li, H. Luo, F. Q. Dai, et al., “SAMD9 promotes Postoperative Recurrence of Esophageal Squamous Cell Carcinoma by Stimulating MYH9-mediated GSK3β/β-catenin Signaling,” Adv Sci (Weinh) 10, no. 11 (2023): e2203573.

[30] W. L. Hu, L. Jin, A. Xu, et al., “GUARDIN Is a p53-responsive Long Non-coding RNA That Is Essential for Genomic Stability,” Nature Cell Biology 20, no. 4 (2018): 492-502.

[31] X. Ren, H. Zhu, K. Deng, et al., “Long Noncoding RNA TPRG1-AS1 Suppresses Migration of Vascular Smooth Muscle Cells and Attenuates Atherogenesis via Interacting With MYH9 Protein,” Arteriosclerosis, Thrombosis, and Vascular Biology 42, no. 11 (2022): 1378-1397.

[32] Y. Li, Z. Wang, P. Su, et al., “circ-EIF6 Encodes EIF6-224aa to Promote TNBC Progression via Stabilizing MYH9 and Activating the Wnt/Beta-catenin Pathway,” Molecular Therapy 30, no. 1 (2022): 415-430.

[33] Q. Zhang, P. Feng, X. H. Zhu, et al., “DNAJA4 suppresses Epithelial-mesenchymal Transition and Metastasis in Nasopharyngeal Carcinoma via PSMD2-mediated MYH9 Degradation,” Cell death & disease 14, no. 10 (2023): 697.

[34] K. N. Swatek and D. Komander, “Ubiquitin Modifications,” Cell Research 26, no. 4 (2016): 399-422.

[35] R. Yang, J. Wan, L. Ma, et al., “TMEM44-AS1 promotes Esophageal Squamous Cell Carcinoma Progression by Regulating the IGF2BP2-GPX4 Axis in Modulating Ferroptosis,” Cell Death Discov 9, no. 1 (2023): 431.

[36] Y. Nan, S. Liu, Q. Luo, et al., “m(6)A Demethylase FTO Stabilizes LINK-A to Exert Oncogenic Roles via MCM3-mediated Cell-cycle Progression and HIF-1α Activation,” Cell reports 42, no. 10 (2023): 113273.

[37] T. P. Xu, P. Ma, W. Y. Wang, et al., “KLF5 and MYC Modulated LINC00346 Contributes to Gastric Cancer Progression Through Acting as a Competing Endogeous RNA and Indicates Poor Outcome,” Cell Death and Differentiation 26, no. 11 (2019): 2179-2193.

[38] C. M. Brennan and J. A. Steitz, “HuR and mRNA Stability,” Cellular and Molecular Life Sciences 58, no. 2 (2001): 266-277.

[39] C. Wang, M. Zhou, P. Zhu, et al., “IGF2BP2-induced circRUNX1 Facilitates the Growth and Metastasis of Esophageal Squamous Cell Carcinoma Through miR-449b-5p/FOXP3 Axis,” Journal of Experimental & Clinical Cancer Research 41, no. 1 (2022): 347.

[40] H. Huang, H. Weng, W. Sun, et al., “Recognition of RNA N-methyladenosine by IGF2BP Proteins Enhances mRNA Stability and Translation,” Nature Cell Biology 20, no. 3 (2018): 285-295.

[41] J. Wang, T. J. Huang, Y. Mei, et al., “Novel Long Noncoding RNA LINC02820 Augments TNF Signaling Pathway to Remodel Cytoskeleton and Potentiate Metastasis in Esophageal Squamous Cell Carcinoma,” Cancer Gene Therapy 30, no. 2 (2023): 375-387.

[42] Q. Gou, L. Gao, X. Nie, et al., “Long Noncoding RNA AB074169 Inhibits Cell Proliferation via Modulation of KHSRP-mediated CDKN1a Expression in Papillary Thyroid Carcinoma,” Cancer Research 78, no. 15 (2018): 4163-4174.

[43] X. Lin, A. M. Li, Y. H. Li, et al., “Silencing MYH9 Blocks HBx-induced GSK3β Ubiquitination and Degradation to Inhibit Tumor Stemness in Hepatocellular Carcinoma,” Signal Transduct Target Ther 5, no. 1 (2020): 13.

[44] Y. Zhong, T. Long, C. S. Gu, et al., “MYH9-dependent Polarization of ATG9B Promotes Colorectal Cancer Metastasis by Accelerating Focal Adhesion Assembly,” Cell Death and Differentiation 28, no. 12 (2021): 3251-3269.

[45] S. Gao, S. Wang, Z. Zhao, et al., “TUBB4A interacts With MYH9 to Protect the Nucleus During Cell Migration and Promotes Prostate Cancer via GSK3β/β-catenin Signalling,” Nature Communications 13, no. 1 (2022): 2792.

[46] C. Wang, W. R. Liu, S. Tan, et al., “Characterization of Distinct Circular RNA Signatures in Solid Tumors,” Molecular cancer 21, no. 1 (2022): 63.

[47] A. M. Bolger, M. Lohse, and B. Usadel, “Trimmomatic: A Flexible Trimmer for Illumina Sequence Data,” Bioinformatics 30, no. 15 (2014): 2114-2120.

[48] D. Kim, B. Langmead, and S. L. Salzberg, “HISAT: A Fast Spliced Aligner With Low Memory Requirements,” Nature Methods 12, no. 4 (2015): 357-360.

[49] M. Pertea, G. M. Pertea, C. M. Antonescu, et al., “StringTie Enables Improved Reconstruction of a Transcriptome From RNA-seq Reads,” Nature Biotechnology 33, no. 3 (2015): 290-295.

[50] M. I. Love, W. Huber, and S. Anders, “Moderated Estimation of Fold Change and Dispersion for RNA-seq Data With DESeq2,” Genome biology 15, no. 12 (2014): 550.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.